Examination of CD109 expression in head and neck cancer

Examination of CD109 expression in head and neck cancer - Examination of CD109 expression in head and neck cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041971

Enrollment

500

Registered

2020-10-01

Start date

2019-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Among patients treated for head and neck cancer at Kitasato University Hospital between January 1, 2008 and December 31, 2013, biopsy was performed at Kitasato University Hospital Pathology Department and Otolaryngology / Head and Neck Surgery Patients with preserved formalin-fixed paraffin-embedded specimens of tissue and surgically resected tissue

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Correlation between the presence or absence of CD109 expression and OS and PFS	—

Countries

Japan

Contacts

Public ContactShohei Tsutsumi

Kitasato University Otorhinolaryngology / Head and Neck Surgery

s08tsutsumi@gmail.com042-778-8111

Outcome results